Search results for 'media+pharma'

What Dilip Shanghvi said on Sun Pharma's Organon Buy

What Dilip Shanghvi said on Sun Pharma's Organon Buy

Rediff.com27 Apr 2026

Sun Pharmaceutical Industries' Executive Chairman Dilip Shanghvi described the USD 11.75 billion acquisition of US-based Organon & Co as both a "happy" and "bit anxious" moment, acknowledging the significant debt required to fund the large transaction.

Novartis Launches Prostate Cancer Radiotherapy

Novartis Launches Prostate Cancer Radiotherapy

Rediff.com23 Jun 2026

The launch highlights the growing maturity of India's nuclear medicine ecosystem.

Stock markets today: Sensex, Nifty slump on global cues

Stock markets today: Sensex, Nifty slump on global cues

Rediff.com8 Jun 2026

Indian benchmark indices Sensex and Nifty experienced a significant slump in early trade, mirroring a sharp decline in global equities and a fresh spike in crude oil prices, exacerbated by simmering tensions in West Asia and a global unwinding of the AI-led rally. Track how sensex, Nifty fared on June 8.

'Biggest Single Danger Is If Remittances Come Down'

'Biggest Single Danger Is If Remittances Come Down'

Rediff.com13 May 2026

'At the first sign of real trouble, that money will move. There will be a run.'

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Rediff.com9 Apr 2026

'The unregulated marketing has to stop. People are getting recommendations for this from gym trainers, from marriage counsellors -- that is simply unacceptable.' ''There are many ways to lose weight -- eat less, fast, exercise, eat healthy. That is how you lose weight.'

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Rediff.com26 Sep 2025

Most pharma shares dropped, dragging the BSE Healthcare index down by 2.14 per cent after Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1. Wockhardt shares tanked 9.4 per cent.

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Rediff.com26 Sep 2025

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.

Stock Market Today: Sensex, Nifty suffer major meltdown as West Asia crisis intensifies

Stock Market Today: Sensex, Nifty suffer major meltdown as West Asia crisis intensifies

Rediff.com2 Mar 2026

Indian benchmark equity indices Sensex and Nifty experienced a significant crash in early trade, triggered by a sharp increase in crude oil prices and escalating tensions in the Middle East.

Indian Exports See Marginal Decline in February Amid Geopolitical Tensions

Indian Exports See Marginal Decline in February Amid Geopolitical Tensions

Rediff.com16 Mar 2026

India's merchandise exports experienced a slight decrease in February, while imports surged due to increased gold and silver purchases, leading to a widened trade deficit. The West Asia crisis is expected to further impact trade in the coming months.

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

JioHotStar Is Investing 4K Cr In South!

JioHotStar Is Investing 4K Cr In South!

Rediff.com10 Dec 2025

The platform has seen a growth of 70% in watch time for South content, which is more than the national average.The South has outperformed the rest of India in subscription depth, retention and connected TV adoption.

Will India continue to remain an attractive FDI destination in 2026?

Will India continue to remain an attractive FDI destination in 2026?

Rediff.com27 Dec 2025

FDI inflows into India are expected to register robust growth in 2026, supported by strong macroeconomic fundamentals, big-ticket investment announcements, sustained efforts to improve the ease of doing business, and a new generation of investment-linked trade pacts.

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

The Lady Who Designed The Billionaire Wedding

The Lady Who Designed The Billionaire Wedding

Rediff.com9 Dec 2025

When Chennai-based Wedding Designer Ambika Gupta first received a brief for a destination wedding in Udaipur, she had no idea it would turn into one of the most high-profile celebrations of the season.

Modi and Putin: Hug in airport, ride in car, dinner at 7, LKM

Modi and Putin: Hug in airport, ride in car, dinner at 7, LKM

Rediff.com5 Dec 2025

Russian President Vladimir Putin arrived in New Delhi for a two-day visit focused on strengthening ties with India, including defense cooperation and trade, amidst a changing geopolitical landscape.

How To Choose MFs Smartly

How To Choose MFs Smartly

Rediff.com3 Dec 2025

Investors who constantly hop between 'top-performing' funds often end up earning far lower returns than the very funds they invest in -- simply because they enter late and exit early. Best investors don't chase returns, they chase discipline, says Ramalingam Kalirajan.

Pharma companies fight fakes with smart packaging

Pharma companies fight fakes with smart packaging

Rediff.com10 Oct 2024

Indian pharmaceutical companies are stepping up their efforts to combat the problem of counterfeit drugs, employing a variety of strategies, from packaging innovations to engaging private investigation agencies. The stakes are high, as counterfeit medicines not only harm consumers but also tarnish the reputation of leading brands.

3 cough syrups have been recalled: India replies to WHO

3 cough syrups have been recalled: India replies to WHO

Rediff.com9 Oct 2025

India's drug regulator CDSCO has recalled three cough syrups and halted their production after the WHO raised concerns about potential contamination and links to child deaths. The WHO is investigating reports of pediatric illnesses and deaths in India potentially linked to contaminated syrups.

Russia strikes Indian pharma warehouse in Ukraine

Russia strikes Indian pharma warehouse in Ukraine

Rediff.com13 Apr 2025

A Russian missile struck a warehouse belonging to an Indian pharmaceutical company, Kusum, in Ukraine, according to the Ukrainian embassy in India. The embassy alleged that Russia, despite claiming a "special friendship" with India, deliberately targeted Indian businesses in Ukraine. The strike reportedly destroyed medicines intended for children and the elderly. This incident follows a similar attack on a major pharmaceuticals warehouse in Kyiv, which was destroyed by Russian drones, as reported by the UK's ambassador to Ukraine. Kusum Healthcare, the company whose warehouse was hit, has a presence in 29 countries, including Ukraine. This attack comes amidst ongoing tensions in the region as Russia continues its offensive against Ukraine, despite US efforts to push for a ceasefire. Ukrainian Foreign Minister Andrii Sybiha accused Russia of being the sole obstacle to peace and claimed that Moscow rejected a US-brokered proposal for a ceasefire.

J-K pharma student thrashed in Nagpur; Fadnavis's intervention sought

J-K pharma student thrashed in Nagpur; Fadnavis's intervention sought

Rediff.com29 Apr 2025

A student from Jammu and Kashmir studying at a pharmacy college in Nagpur was thrashed by a group of local residents, prompting police to investigate the incident. The student, who ruled out a hate motive, said he was attacked by "anti-social elements" after being questioned about his origin. The J&K Students Association has called for action against the perpetrators.

India's Foreign Policy Panchnama

India's Foreign Policy Panchnama

Rediff.com4 Oct 2025

There has never been a moment in India's history when it has been so adrift in the world, so confused about what it stands for and against and so humiliated, asserts Aakar Patel.

Kerala's SMA Treatment Model Offers Hope

Kerala's SMA Treatment Model Offers Hope

Rediff.com2 Sep 2025

The Kerala model is crucial as SMA patients in India had a long wait for a viable treatment option.

'Trump Is Frustrated'

'Trump Is Frustrated'

Rediff.com4 Aug 2025

'What India has done will surely embolden more countries to stand up to Trump.'

Why Stock Tips Won't Build Wealth For You

Why Stock Tips Won't Build Wealth For You

Rediff.com3 Sep 2025

Real wealth isn't built on random bets; it's built on disciplined, guided portfolio strategies that can withstand market ups and downs, says Ramalingam Kalirajan.

Trump's Tariffs: Why India Needs To Be Strategic

Trump's Tariffs: Why India Needs To Be Strategic

Rediff.com12 Aug 2025

In trade negotiations, as in chess, sometimes you need to accept a temporary disadvantage to secure a better long-term position, points out Sonal Varma, chief economist (India and Asia ex-Japan) at Nomura.

Exports fall 2.17% in May; trade deficit narrows

Exports fall 2.17% in May; trade deficit narrows

Rediff.com16 Jun 2025

After registering a positive growth for two months, India's exports slipped into negative territory again, contracting 2.17 per cent year-on-year to $38.73 billion in May due to a fall in global petroleum prices, while trade deficit narrowed at $21.88 billion during the month.

Dialogue, not battlefields, key to global peace: Modi in Croatia

Dialogue, not battlefields, key to global peace: Modi in Croatia

Rediff.com19 Jun 2025

In his media statement following talks with his Croatian counterpart Andrej Plenkovic, Modi said both leaders agree that "terrorism is an enemy of humanity" and is inimical to forces that believe in democracy.

India sees record deal activity in Feb at $7.2 bn

India sees record deal activity in Feb at $7.2 bn

Rediff.com15 Mar 2025

India witnessed a record-breaking surge in deal activity in February, with 226 M&A and private equity deals totaling $7.2 billion -- the highest monthly deal volume in the last three years, according to the Dealtracker report of Grant Thornton Bharat. "This represents a 67 per cent increase in volumes and a 5.4-fold increase in values compared to February 2024, while a 14 per cent increase over the previous month," it said.

Dabba Cartel Review: High Five!

Dabba Cartel Review: High Five!

Rediff.com28 Feb 2025

Dabba Cartel's reluctant black comedy in the body of a crime thriller starts out interestingly enough to accomplish its Narcos: Thane aspirations, notes Sukanya Verma.

PE fund Advent to buy Suven Pharma

PE fund Advent to buy Suven Pharma

Rediff.com26 Dec 2022

Global private equity investor Advent International on Monday said it is acquiring a significant stake in Suven Pharmaceuticals from its promoters, the Jasti family. The PE major said this will be followed with an open offer to acquire 26 per cent more in the listed contract development and manufacturing organisation from public shareholders, and also merge the company with investee company Cohance Lifesciences, as per an official statement. Media reports on a Monday morning pegged the acquisition at Rs 6,300 crore, and that Advent had pipped rival Blackstone for the acquisition.

Modi raises anti-India activities in NZ with visiting PM

Modi raises anti-India activities in NZ with visiting PM

Rediff.com17 Mar 2025

India and New Zealand have signed a pact to institutionalize their defence ties and vowed to boost cooperation in the Indo-Pacific. Prime Minister Narendra Modi raised concerns about anti-India activities by some illegal elements in New Zealand with his Kiwi counterpart Christopher Luxon. The two sides also signed six agreements to enhance cooperation in areas including education, sports, agriculture, and climate change. They also agreed to prepare a roadmap for cooperation in the defence industry sector and explore early implementation of cooperation in the digital payments sector.

Budget 2025: Consumption-related stocks likely to see further gains

Budget 2025: Consumption-related stocks likely to see further gains

Rediff.com3 Feb 2025

Market reaction to the Union Budget was overall neutral. The income tax "gift" wasn't enough to move the needle. There was some apparent rationalisation of Customs duty structure as well as cuts on import duties of some key components for the telecom and IT industry and duty cuts on vehicle imports. Other proposals related to development of agriculture and rural economy and renewables seem to be generally positive.

Engineer arrested for post on bomb threat at Ambani wedding

Engineer arrested for post on bomb threat at Ambani wedding

Rediff.com16 Jul 2024

The Mumbai police were on high alert after an X user @ffsfir wrote a post about the potential threat which reads like "My mind is wondering shamelessly that half the world would go upside down tomorrow after a bomb went off at the Ambani wedding. trillions of dollars in one pin code."

2024's 10 Best Web Series

2024's 10 Best Web Series

Rediff.com9 Dec 2024

The year was rich in content as far as Web series were concerned.

Export plunges 9.3%; trade deficit widens to 10-month high

Export plunges 9.3%; trade deficit widens to 10-month high

Rediff.com17 Sep 2024

India's exports registered a steepest decline in 13-month falling 9.3 per cent in August to $34.71 billion due to global economic uncertainties, while the trade deficit soared to a 10-month of $29.65 billion. According to the government data released on Tuesday, imports increased by 3.3 per cent to $64.36 billion, which is a record high, due to a significant jump in the inbound shipments of gold and silver.

Yes Bank to be dropped from Nifty 50 from Mar 27

Yes Bank to be dropped from Nifty 50 from Mar 27

Rediff.com18 Feb 2020

Changes have been made in several indices including Nifty 500, Nifty 200, Nifty 100, Nifty Midcap 150, Nifty Smallcap 250 and host of sectoral indices including FMCG, IT, media, pharma, commodities and services sector.

Goodbye Skipper!

Goodbye Skipper!

Rediff.com29 Nov 2024

'He asserted in his usual jovial style that he was not an MBA like his audience at IIM-Ahmedabad but perhaps had an even better business degree: MBB'. 'He went on to explain to his perplexed, blue chip B-School audience that MBB stood for "Marwadi by birth"!' Shivanand Kanavi salutes Shashi Ruia, co-founder of the Essar group who passed into the ages on November 25, 2024 in Mumbai.

Why Vettaiyan May Become A Blockbuster

Why Vettaiyan May Become A Blockbuster

Rediff.com8 Oct 2024

'The combination of star power, compelling storytelling, and action-packed drama promises to set the box office ablaze and kickstart the new quarter on a spectacular high note.'

Exports dip 1.2% in Jul; trade deficit widens to $23.5 bn

Exports dip 1.2% in Jul; trade deficit widens to $23.5 bn

Rediff.com14 Aug 2024

After remaining in the positive zone for three months, India's exports contracted 1.2 per cent to $33.98 billion in July, while the trade deficit widened to $23.5 billion.

What industry leaders say on Karnataka's draft reservation bill

What industry leaders say on Karnataka's draft reservation bill

Rediff.com18 Jul 2024

Infosys will comply with whatever regulations and guidelines Karnataka comes up with, a top company official said on Thursday on the proposed reservations for locals in private firms in the state. Infosys employs over 3.15 lakh people at present across the globe. "We are planning to work with all the regulations of the state and central governments.